These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6393859)

  • 21. Investigations on the role of arachidonic acid metabolism pathways in the antithrombotic activity of nafazatrom and molsidomine.
    Massad L; Plotkine M; Boulu RG
    Thromb Res; 1988 Jun; 50(5):617-25. PubMed ID: 3137682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic modification of blood flow in the rabbit microvasculature with prostacyclin and related drugs.
    Knight KR; Crabb DJ; Niall M; Angus JA; Martin TJ; O'Brien BM
    Plast Reconstr Surg; 1985 May; 75(5):692-702. PubMed ID: 3157201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastasis-enhancing effect of heparin and its relationship to a lipoprotein factor.
    Chan SY; Pollard M
    J Natl Cancer Inst; 1980 May; 64(5):1121-5. PubMed ID: 6929014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Nb rat prostatic adenocarcinoma model system.
    Drago JR; Goldman LB; Maurer RE
    Prog Clin Biol Res; 1980; 37():265-91. PubMed ID: 7384086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective actions of nafazatrom in traumatic shock.
    Lefer AM; Messenger M
    Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.
    Keith RL; Miller YE; Hudish TM; Girod CE; Sotto-Santiago S; Franklin WA; Nemenoff RA; March TH; Nana-Sinkam SP; Geraci MW
    Cancer Res; 2004 Aug; 64(16):5897-904. PubMed ID: 15313935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
    Narayanan BA; Reddy BS; Bosland MC; Nargi D; Horton L; Randolph C; Narayanan NK
    Clin Cancer Res; 2007 Oct; 13(19):5965-73. PubMed ID: 17908994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
    Ermert L; Dierkes C; Ermert M
    Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells.
    Andrews P; Krygier S; Djakiew D
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):179-86. PubMed ID: 11935209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
    Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
    Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anti-metastatic effect of intravenously-inoculated BCG on prostate tumor cells.
    Pollard M; Luckert PH
    Anticancer Res; 1993; 13(3):705-8. PubMed ID: 8317900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor.
    Zeng Y; Yokohira M; Saoo K; Takeuchi H; Chen Y; Yamakawa K; Matsuda Y; Kakehi Y; Imaida K
    Carcinogenesis; 2005 Jun; 26(6):1109-16. PubMed ID: 15731164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synthesis of prostaglandins by the Nb rat prostate tumor.
    Drago JR; Rohner TJ; Demers LM
    Anticancer Res; 1985; 5(4):393-5. PubMed ID: 4037734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of metastasis by cicaprost in rats with established SMT2A mammary carcinoma growth.
    Schirner M; Schneider MR
    Cancer Detect Prev; 1997; 21(1):44-50. PubMed ID: 9043762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms.
    Copeland JN; Amin MB; Humphrey PA; Tamboli P; Ro JY; Gal AA
    Am J Clin Pathol; 2002 Apr; 117(4):552-7. PubMed ID: 11939729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery.
    Shibata T; Yamashita T; Suzuki K; Takeichi N; Micallef M; Hosokawa M; Kobayashi H; Murata M; Arisue M
    Anticancer Res; 1998; 18(6A):4443-8. PubMed ID: 9891507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
    Sosnowski J; Stetter-Neel C; Cole D; Durham JP; Mawhinney MG
    J Urol; 1997 Jul; 158(1):269-74. PubMed ID: 9186373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nafazatrom and indomethacin on experimental myocardial ischemia in the anesthetized dog.
    Fiedler VB; Mardin M
    J Cardiovasc Pharmacol; 1985; 7(5):983-9. PubMed ID: 2413312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.